Skip to content
Disclosery

Eversept Partners, LP

Follow

13F filer, CIK 1697013, NEW YORK, NY

Eversept Partners, LP reported $1,927,640,043 across 120 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 46.64% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697013-26-000005

Period
2026-06-30
Reported value
$1.93B
Holdings
120
Top 10 weight
46.64%
New
32
Sold out
32

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ENSGadded+587,318$94.1M
EHCadded+832,815$84.2M
CTREnew+1,072,015$43.3M
UNHnew+51,145$21.3M
COGTnew+490,235$19M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GSKreduced-1,303,342-$68.3M
NTRAreduced-208,906-$56.7M
DOCexited-1,981,070-$32.5M
AVTRexited-2,974,287-$23.3M
QGENexited-545,330-$21.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001697013-26-000005, largest first. % of portfolio is the value over $1,834,367,679, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 130,949 shares; 2024Q4: 43,703 shares; 2025Q1: 57,489 shares; 2025Q2: 59,366 shares; 2025Q3: 253,220 shares; 2025Q4: 252,592 shares; 2026Q1: 264,271 shares; 2026Q2: 287,668 shares 287,668$156M8.5%+23,397Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 426,499 shares; 2025Q4: 657,834 shares; 2026Q1: 934,423 shares; 2026Q2: 913,880 shares 913,880$122M6.64%-20,543Timeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,926 shares; 2026Q1: 194,104 shares; 2026Q2: 1,026,919 shares 1,026,919$104M5.66%+832,815Timeline
ENSGENSIGN GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 14,761 shares; 2026Q2: 602,079 shares 602,079$96.5M5.26%+587,318Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 2,050,157 shares; 2024Q4: 1,600,015 shares; 2025Q1: 1,898,804 shares; 2025Q2: 2,383,055 shares; 2025Q3: 2,807,836 shares; 2025Q4: 3,072,304 shares; 2026Q1: 2,173,286 shares; 2026Q2: 2,212,770 shares 2,212,770$94.9M5.18%+39,484Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 564,902 shares; 2024Q4: 719,836 shares; 2025Q1: 696,499 shares; 2025Q2: 838,736 shares; 2025Q3: 1,153,920 shares; 2025Q4: 1,434,725 shares; 2026Q1: 1,788,016 shares; 2026Q2: 1,785,941 shares 1,785,941$66.5M3.62%-2,075Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,105,313 shares; 2024Q4: 343,400 shares; 2025Q1: 4,212,270 shares; 2025Q2: 4,065,355 shares; 2025Q3: 3,467,314 shares; 2025Q4: 3,314,408 shares; 2026Q1: 2,885,622 shares; 2026Q2: 2,798,210 shares 2,798,210$61.2M3.33%-87,412Timeline
BKDBROOKDALE SR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 861,268 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 374,929 shares; 2026Q1: 3,568,555 shares; 2026Q2: 3,396,470 shares 3,396,470$54.6M2.98%-172,085Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 471,355 shares; 2024Q4: 214,952 shares; 2025Q1: 517,021 shares; 2025Q2: 588,900 shares; 2025Q3: 538,661 shares; 2025Q4: 538,218 shares; 2026Q1: 632,100 shares; 2026Q2: 664,684 shares 664,684$52.7M2.87%+32,584Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 870,193 shares; 2024Q4: 876,766 shares; 2025Q1: 893,721 shares; 2025Q2: 796,375 shares; 2025Q3: 519,644 shares; 2025Q4: 334,493 shares; 2026Q1: 384,713 shares; 2026Q2: 175,807 shares 175,807$47.7M2.6%-208,906Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 869,913 shares; 2024Q4: 490,296 shares; 2025Q1: 816,254 shares; 2025Q2: 1,315,033 shares; 2025Q3: 1,417,204 shares; 2025Q4: 1,174,968 shares; 2026Q1: 542,610 shares; 2026Q2: 798,973 shares 798,973$45.4M2.47%+256,363Timeline
CTRECARETRUST REIT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,072,015 shares 1,072,015$43.3M2.36%newTimeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 129,084 shares; 2024Q4: 175,808 shares; 2025Q1: 152,502 shares; 2025Q2: 99,983 shares; 2025Q3: 111,700 shares; 2025Q4: 95,874 shares; 2026Q1: 79,229 shares; 2026Q2: 98,252 shares 98,252$38.3M2.09%+19,023Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 127,588 shares; 2025Q1: 557,070 shares; 2025Q2: 1,298,514 shares; 2025Q3: 1,421,983 shares; 2025Q4: 1,197,722 shares; 2026Q1: 924,193 shares; 2026Q2: 629,952 shares 629,952$36.6M2%-294,241Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 137,949 shares; 2024Q4: 571,305 shares; 2025Q1: 150,480 shares; 2025Q2: 358,828 shares; 2025Q3: 486,021 shares; 2025Q4: 509,443 shares; 2026Q1: 677,392 shares; 2026Q2: 428,652 shares 428,652$34.2M1.86%-248,740Timeline
CYHCOMMUNITY HEALTH SYS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 8,776,455 shares; 2024Q4: 2,827,000 shares; 2025Q1: 8,458,020 shares; 2025Q2: 6,144,384 shares; 2025Q3: 6,950,051 shares; 2025Q4: 7,943,802 shares; 2026Q1: 8,677,281 shares; 2026Q2: 7,864,575 shares 7,864,575$26.3M1.43%-812,706Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,057,206 shares; 2024Q4: 3,661,768 shares; 2025Q1: 2,623,246 shares; 2025Q2: 2,242,388 shares; 2025Q3: 2,120,446 shares; 2025Q4: 2,679,721 shares; 2026Q1: 1,785,175 shares; 2026Q2: 481,833 shares 481,833$25.3M1.38%-1,303,342Timeline
CHECHEMED CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 31,057 shares; 2026Q2: 52,523 shares 52,523$24.5M1.33%+21,466Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,623 shares; 2026Q1: 19,000 shares; 2026Q2: 20,116 shares 20,116$24.1M1.32%+1,116Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,320,174 shares; 2025Q3: 12,599,002 shares; 2025Q4: 17,659,983 shares; 2026Q1: 18,834,883 shares; 2026Q2: 18,717,422 shares 18,717,422$24M1.31%-117,461Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 239,110 shares; 2026Q2: 602,922 shares 602,922$23.5M1.28%+363,812Timeline
OHIOMEGA HEALTHCARE INVS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 585,680 shares; 2026Q2: 483,547 shares 483,547$23.1M1.26%-102,133Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 45,604 shares; 2025Q4: 74,708 shares; 2026Q1: 143,546 shares; 2026Q2: 148,816 shares 148,816$22.7M1.24%+5,270Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 29,512 shares; 2026Q2: 114,199 shares 114,199$21.4M1.16%+84,687Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 60,736 shares; 2025Q3: 62,820 shares; 2025Q4: 60,862 shares; 2026Q1: not reported; 2026Q2: 51,145 shares 51,145$21.3M1.16%newTimeline
WELLWELLTOWER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 180,953 shares; 2026Q2: 87,312 shares 87,312$19.8M1.08%-93,641Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 678,262 shares; 2026Q1: 1,414,838 shares; 2026Q2: 1,249,441 shares 1,249,441$19.6M1.07%-165,397Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 490,235 shares 490,235$19M1.03%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 535,405 shares; 2024Q4: 1,980,312 shares; 2025Q1: 2,172,436 shares; 2025Q2: 1,207,638 shares; 2025Q3: 1,373,625 shares; 2025Q4: 2,992,895 shares; 2026Q1: 3,039,820 shares; 2026Q2: 1,865,653 shares 1,865,653$18.7M1.02%-1,174,167Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,588 shares; 2024Q4: not reported; 2025Q1: 23,735 shares; 2025Q2: 20,600 shares; 2025Q3: 9,470 shares; 2025Q4: 45,470 shares; 2026Q1: 32,811 shares; 2026Q2: 80,594 shares 80,594$18.4M1%+47,783Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,980 shares; 2025Q3: 37,980 shares; 2025Q4: 293,960 shares; 2026Q1: 312,178 shares; 2026Q2: 460,272 shares 460,272$17M0.93%+148,094Timeline
LTCLTC PPTYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 321,046 shares; 2026Q2: 420,640 shares 420,640$16.2M0.88%+99,594Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,089,404 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 149,209 shares 149,209$15.9M0.87%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 691,232 shares; 2024Q4: 779,998 shares; 2025Q1: 1,377,674 shares; 2025Q2: 1,902,539 shares; 2025Q3: 1,924,306 shares; 2025Q4: 1,782,235 shares; 2026Q1: 713,269 shares; 2026Q2: 831,142 shares 831,142$15.3M0.83%+117,873Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 146,642 shares; 2025Q4: 93,748 shares; 2026Q1: 207,768 shares; 2026Q2: 249,607 shares 249,607$14.3M0.78%+41,839Timeline
AMNAMN HEALTHCARE SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 428,531 shares 428,531$13.9M0.76%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 127,931 shares 127,931$13.4M0.73%newTimeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 439,177 shares; 2026Q1: 406,960 shares; 2026Q2: 386,383 shares 386,383$13.4M0.73%-20,577Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,507,090 shares; 2026Q1: 3,188,514 shares; 2026Q2: 3,558,497 shares 3,558,497$13.3M0.73%+369,983Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 33,860 shares; 2024Q4: 22,682 shares; 2025Q1: 27,970 shares; 2025Q2: 43,620 shares; 2025Q3: 16,652 shares; 2025Q4: 32,462 shares; 2026Q1: not reported; 2026Q2: 31,171 shares 31,171$12.4M0.67%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 155,540 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 231,380 shares; 2026Q1: 129,574 shares; 2026Q2: 196,532 shares 196,532$11.9M0.65%+66,958Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 747,994 shares 747,994$11.2M0.61%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 41,621 shares 41,621$11.1M0.61%newTimeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 234,934 shares; 2025Q1: 499,207 shares; 2025Q2: 839,284 shares; 2025Q3: 687,129 shares; 2025Q4: 783,789 shares; 2026Q1: 117,013 shares; 2026Q2: 182,894 shares 182,894$11M0.6%+65,881Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 267,823 shares; 2026Q1: 159,708 shares; 2026Q2: 152,122 shares 152,122$10.7M0.58%-7,586Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 99,338 shares; 2025Q3: 166,391 shares; 2025Q4: 127,561 shares; 2026Q1: 138,036 shares; 2026Q2: 196,302 shares 196,302$10.5M0.57%+58,266Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 160,723 shares; 2026Q2: 217,185 shares 217,185$10.2M0.56%+56,462Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 677,924 shares; 2026Q2: 672,825 shares 672,825$9.52M0.52%-5,099Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 307,357 shares; 2024Q4: 275,362 shares; 2025Q1: 280,951 shares; 2025Q2: 414,430 shares; 2025Q3: 488,592 shares; 2025Q4: 420,827 shares; 2026Q1: 285,764 shares; 2026Q2: 275,471 shares 275,471$9.34M0.51%-10,293Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 469,692 shares; 2024Q4: 392,518 shares; 2025Q1: 299,087 shares; 2025Q2: 510,330 shares; 2025Q3: 394,311 shares; 2025Q4: 162,777 shares; 2026Q1: 84,854 shares; 2026Q2: 83,624 shares 83,624$9.3M0.51%-1,230Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,391,548 shares; 2026Q1: 4,987,499 shares; 2026Q2: 4,182,785 shares 4,182,785$8.74M0.48%-804,714Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,429,377 shares; 2025Q4: 1,715,129 shares; 2026Q1: 2,229,446 shares; 2026Q2: 1,678,345 shares 1,678,345$8.56M0.47%-551,101Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 309,689 shares 309,689$8.36M0.46%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 533,409 shares; 2025Q3: 479,056 shares; 2025Q4: 489,137 shares; 2026Q1: 270,705 shares; 2026Q2: 434,314 shares 434,314$8.13M0.44%+163,609Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 217,708 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 169,227 shares 169,227$8.11M0.44%newTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 132,537 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 145,431 shares; 2026Q1: not reported; 2026Q2: 515,804 shares 515,804$7.68M0.42%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 445,204 shares; 2024Q4: 678,787 shares; 2025Q1: 547,116 shares; 2025Q2: 277,316 shares; 2025Q3: not reported; 2025Q4: 52,961 shares; 2026Q1: not reported; 2026Q2: 58,504 shares 58,504$7.17M0.39%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 136,631 shares 136,631$6.93M0.38%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,992 shares; 2025Q4: not reported; 2026Q1: 334,861 shares; 2026Q2: 590,252 shares 590,252$6.53M0.36%+255,391Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,198 shares; 2026Q2: 183,663 shares 183,663$5.96M0.32%+83,465Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 166,289 shares 166,289$5.71M0.31%newTimeline
NHINATIONAL HEALTH INVS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 70,673 shares 70,673$5.39M0.29%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 317,182 shares; 2026Q1: 62,575 shares; 2026Q2: 154,130 shares 154,130$5.15M0.28%+91,555Timeline
PACSPACS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 117,441 shares 117,441$5.01M0.27%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,498,993 shares; 2026Q2: 1,520,824 shares 1,520,824$4.87M0.27%+21,831Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 120,927 shares; 2026Q1: 27,089 shares; 2026Q2: 69,983 shares 69,983$4.72M0.26%+42,894Timeline
NHCNATIONAL HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 28,577 shares; 2026Q1: not reported; 2026Q2: 22,116 shares 22,116$4.67M0.25%newTimeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 297,735 shares 297,735$4.26M0.23%newTimeline
SNDASONIDA SENIOR LIVING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,437 shares; 2026Q2: 102,624 shares 102,624$4.19M0.23%+74,187Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 158,957 shares; 2025Q2: 31,496 shares; 2025Q3: not reported; 2025Q4: 147,471 shares; 2026Q1: 60,214 shares; 2026Q2: 29,343 shares 29,343$4.1M0.22%-30,871Timeline
AGLAGILON HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 176,588 shares; 2026Q2: 37,792 shares 37,792$4.05M0.22%-138,796Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 693,263 shares; 2024Q4: 191,158 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 111,466 shares; 2025Q4: 434,634 shares; 2026Q1: 576,580 shares; 2026Q2: 135,355 shares 135,355$3.55M0.19%-441,225Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 55,710 shares 55,710$3.51M0.19%newTimeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,168 shares; 2026Q2: 128,286 shares 128,286$3.39M0.18%+3,118Timeline
SPRYARS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 976,511 shares; 2025Q4: 251,593 shares; 2026Q1: 136,235 shares; 2026Q2: 377,007 shares 377,007$3.02M0.16%+240,772Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,621,787 shares; 2024Q4: 492,452 shares; 2025Q1: 1,675,978 shares; 2025Q2: 1,640,430 shares; 2025Q3: 1,730,635 shares; 2025Q4: 1,757,312 shares; 2026Q1: 1,758,573 shares; 2026Q2: 1,304,069 shares 1,304,069$2.92M0.16%-454,504Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,426 shares; 2025Q4: 18,062 shares; 2026Q1: 11,119 shares; 2026Q2: 7,241 shares 7,241$2.88M0.16%-3,878Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 332,756 shares; 2024Q4: 200,095 shares; 2025Q1: 617,418 shares; 2025Q2: 1,986,072 shares; 2025Q3: 1,488,725 shares; 2025Q4: 1,006,163 shares; 2026Q1: 1,351,106 shares; 2026Q2: 1,423,873 shares 1,423,873$2.86M0.16%+72,767Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 149,681 shares 149,681$2.76M0.15%newTimeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 190,000 shares 190,000$2.75M0.15%newTimeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 257,154 shares; 2025Q2: 257,154 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 276,174 shares; 2026Q2: 276,174 shares 276,174$2.7M0.15%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,348,360 shares; 2026Q2: 1,890,904 shares 1,890,904$2.53M0.14%-457,456Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 134,619 shares; 2025Q4: 137,493 shares; 2026Q1: 146,411 shares; 2026Q2: 148,017 shares 148,017$2.43M0.13%+1,606Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 54,680 shares; 2026Q2: 174,460 shares 174,460$2.32M0.13%+119,780Timeline
AMRNAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 167,276 shares; 2025Q3: 167,276 shares; 2025Q4: 172,188 shares; 2026Q1: 147,715 shares; 2026Q2: 145,296 shares 145,296$2.32M0.13%-2,419Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,000 shares 40,000$2.16M0.12%newTimeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 163,593 shares; 2024Q4: 54,066 shares; 2025Q1: 18,452 shares; 2025Q2: 18,620 shares; 2025Q3: 105,087 shares; 2025Q4: not reported; 2026Q1: 120,785 shares; 2026Q2: 14,401 shares 14,401$1.96M0.11%-106,384Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,047,265 shares; 2025Q4: 2,140,130 shares; 2026Q1: 2,276,349 shares; 2026Q2: 2,237,015 shares 2,237,015$1.95M0.11%-39,334Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,022,265 shares 1,022,265$1.9M0.1%newTimeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 756,600 shares; 2026Q2: 772,900 shares 772,900$1.75M0.1%+16,300Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 401,187 shares; 2026Q2: 166,229 shares 166,229$1.64M0.09%-234,958Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 250,000 shares; 2026Q2: 156,636 shares 156,636$1.6M0.09%-93,364Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 290,919 shares; 2026Q1: 290,919 shares; 2026Q2: 458,809 shares 458,809$1.49M0.08%+167,890Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 260,259 shares; 2026Q1: 306,800 shares; 2026Q2: 303,306 shares 303,306$1.39M0.08%-3,494Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 663,573 shares; 2024Q4: 299,310 shares; 2025Q1: 280,117 shares; 2025Q2: 394,139 shares; 2025Q3: 591,540 shares; 2025Q4: 377,405 shares; 2026Q1: 125,896 shares; 2026Q2: 19,308 shares 19,308$1.36M0.07%-106,588Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,943 shares 6,943$1.3M0.07%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 170,195 shares; 2026Q1: 384,264 shares; 2026Q2: 204,428 shares 204,428$1.26M0.07%-179,836Timeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 76,997 shares; 2025Q4: 95,286 shares; 2026Q1: 58,624 shares; 2026Q2: 47,777 shares 47,777$1.24M0.07%-10,847Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,035,360 shares; 2026Q2: 1,035,360 shares 1,035,360$1.14M0.06%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 824,594 shares; 2025Q4: 842,023 shares; 2026Q1: 891,425 shares; 2026Q2: 891,425 shares 891,425$1.02M0.06%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 146,403 shares 146,403$968K0.05%newTimeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,658 shares 49,658$929K0.05%newTimeline
ENGNENGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 469,584 shares 469,584$812K0.04%newTimeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 211,469 shares; 2025Q3: 194,440 shares; 2025Q4: 178,915 shares; 2026Q1: 190,715 shares; 2026Q2: 190,715 shares 190,715$809K0.04%0Timeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 294,989 shares; 2026Q2: 294,989 shares 294,989$755K0.04%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 277,899 shares; 2026Q2: 93,192 shares 93,192$645K0.04%-184,707Timeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 89,220 shares; 2025Q2: 128,322 shares; 2025Q3: 128,322 shares; 2025Q4: 222,570 shares; 2026Q1: 220,915 shares; 2026Q2: 404,854 shares 404,854$603K0.03%+183,939Timeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,430 shares 102,430$540K0.03%newTimeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 427,095 shares 427,095$487K0.03%newTimeline
SSIISS INNOVATIONS INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,358 shares; 2026Q1: 110,157 shares; 2026Q2: 110,157 shares 110,157$457K0.02%0Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 159,676 shares; 2026Q1: 40,889 shares; 2026Q2: 16,510 shares 16,510$454K0.02%-24,379Timeline
RVPRETRACTABLE TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 363,315 shares; 2025Q4: 580,919 shares; 2026Q1: 580,919 shares; 2026Q2: 580,919 shares 580,919$418K0.02%0Timeline
SLQTSELECTQUOTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 357,661 shares; 2026Q1: 357,661 shares; 2026Q2: 319,788 shares 319,788$269K0.01%-37,873Timeline
GHRSGH RESEARCH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,672 shares 8,672$233K0.01%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000$185K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput98,600$72.6M-140,100
INSMINSMED INC Stockcall96,600$10.3M+2,600
XBISPDR SERIES TRUST S&P BIOTECHput31,000$4.91M+1,000
UHSUNIVERSAL HLTH SVCS INC Stockput18,800$2.8M+600
QGENQIAGEN NV Stockcall68,100$2.66M-408,200

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPYSTATE STR SPDR S&P 500 ETF T107,000$69.6Mput
VRTXVERTEX PHARMACEUTICALS INC90,000$40.2Mcall
TLTISHARES TR428,800$37.2Mput
DOCHEALTHPEAK PROPERTIES INC1,981,070$32.5Mshares
AVTRAVANTOR INC2,974,287$23.3Mshares
QGENQIAGEN NV545,330$21.8Mshares
HYGISHARES TR180,000$14.3Mput
UNHUNITEDHEALTH GROUP INC40,000$10.8Mcall
IWMISHARES TR40,000$9.92Mput
XLKSELECT SECTOR SPDR TR70,000$9.3Mput
ICLRICON PUB LTD CO68,688$7.6Mshares
AGIOAGIOS PHARMACEUTICALS INC200,000$6.77Mshares
MDGLMADRIGAL PHARMACEUTICALS INC10,000$5.23Mshares
PRAXPRAXIS PRECISION MEDICINES I14,800$4.77Mput
ESPRESPERION THERAPEUTICS INC NE1,735,963$4.76Mshares
HQYHEALTHEQUITY INC51,614$4.31Mshares
DAWNDAY ONE BIOPHARMACEUTICALS I183,902$3.94Mshares
CNCCENTENE CORP DEL111,652$3.66Mshares
ENGNENGENE HOLDINGS INC510,543$3.48Mshares
EHABENHABIT INC227,451$3.2Mshares
XLESELECT SECTOR SPDR TR50,000$3.06Mcall
STROSUTRO BIOPHARMA INC73,161$1.82Mshares
NVCRNOVOCURE LTD134,917$1.47Mshares
BVSBIOVENTUS INC159,110$1.45Mshares
IMCRIMMUNOCORE HLDGS PLC39,238$1.18Mshares
TYRATYRA BIOSCIENCES INC27,055$1.04Mshares
PASGPASSAGE BIO INC131,581$1.03Mshares
DHCDIVERSIFIED HEALTHCARE TR151,283$1Mshares
INMDINMODE LTD67,744$927Kshares
REPLREPLIMUNE GROUP INC52,000$398Kcall
AIRSAIRSCULPT TECHNOLOGIES INC74,139$210Kshares
KPTIKARYOPHARM THERAPEUTICS INC23,800$133Kcall

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697013-26-000005 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001697013-26-000005 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001697013-26-000003 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001697013-26-000002 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001697013-25-000010 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001697013-25-000008 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001697013-25-000005 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001697013-25-000002 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001697013-24-000007 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001697013-24-000006 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001697013-24-000004 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001697013-24-000003 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001697013-23-000037 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000021 Quarter ended 2021-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000030 Quarter ended 2022-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000031 Quarter ended 2022-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000032 Quarter ended 2022-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000029 Quarter ended 2022-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000013 Quarter ended 2019-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000027 Quarter ended 2021-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000023 Quarter ended 2021-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000018 Quarter ended 2020-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000015 Quarter ended 2020-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000036 Quarter ended 2023-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000025 Quarter ended 2021-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000014 Quarter ended 2019-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000017 Quarter ended 2020-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000035 Quarter ended 2023-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000007 Quarter ended 2018-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000012 Quarter ended 2019-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000009 Quarter ended 2018-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000008 Quarter ended 2018-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000028 Quarter ended 2022-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000016 Quarter ended 2020-06-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000010 Quarter ended 2018-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000026 Quarter ended 2021-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000011 Quarter ended 2019-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000033 Quarter ended 2022-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000020 Quarter ended 2020-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000022 Quarter ended 2021-03-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000034 Quarter ended 2022-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000024 Quarter ended 2021-09-302023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000006 Quarter ended 2017-12-312023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000019 Quarter ended 2020-12-312023-11-08acceptance time not in the bulk data set
13F-HR 0001697013-23-000005 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001697013-23-000003 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001655789-23-000002 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001697013-22-000008 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001697013-22-000004 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001697013-22-000003 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001697013-22-000002 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001697013-21-000006 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001697013-21-000005 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001697013-21-000003 Quarter ended 2021-03-312021-05-13acceptance time not in the bulk data set
13F-HR 0001697013-21-000002 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR/A 0001697013-20-000008 Quarter ended 2020-09-302020-11-13acceptance time not in the bulk data set
13F-HR 0001697013-20-000007 Quarter ended 2020-09-302020-11-12acceptance time not in the bulk data set
13F-HR 0001697013-20-000005 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001697013-20-000004 Quarter ended 2020-03-312020-05-13acceptance time not in the bulk data set
13F-HR 0001697013-20-000003 Quarter ended 2019-12-312020-02-13acceptance time not in the bulk data set
13F-HR 0001697013-19-000012 Quarter ended 2019-09-302019-11-13acceptance time not in the bulk data set
13F-HR/A 0001697013-19-000011 Quarter ended 2019-06-302019-10-30acceptance time not in the bulk data set
13F-HR 0001697013-19-000010 Quarter ended 2019-06-302019-08-13acceptance time not in the bulk data set
13F-HR 0001697013-19-000006 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0001697013-19-000003 Quarter ended 2018-12-312019-02-13acceptance time not in the bulk data set
13F-HR 0001697013-18-000011 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001697013-18-000009 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001697013-18-000004 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR/A 0001697013-18-000002 Quarter ended 2017-12-312018-02-13acceptance time not in the bulk data set
13F-HR 0001697013-18-000001 Quarter ended 2017-12-312018-02-12acceptance time not in the bulk data set